— 489 —
Institute on Aging and Alzheimer’s Association Workgroup// Alzheimers Dement.
2011. Vol . 7. P. 270-279.
24. Amsten A.F.T. Stress signaling pathways that impair
prefrontal cortex
structure and function // Nat. Rev. Neurosci. 2009. Vol. 10. P. 410-422.
25. Balodis I.M., Kober H., Worhunsky P.D. et al. Diminished frontostrial acti-
vity during processing of monetary rewards and losses in pathological gambling
// Biol. Psychiatry 2012/ Vol. 71. 749-757.
26. Baumen M.h. Ayestas M.A. Partilla J.S. et al. The
designer methcathi-
none analogs mephedrone and methylone are subtrates
for monoamine transpor-
ters in brain tissue // Neuropsychopharmarmacology 2012. Vol 37 P. 1192-1203.
27. Berridge C.W., Shumskiy J.S., Andrzejewski M.E. et al. Differential sen-
sitivity to psychostimulants across prefrontal cognitive tasks:
differential involve-
ment of noradrenergic al- and a2-receptors // Biol. Psychiatry. 2012. Vol. 71. P.
467-473.
28. Bradberry C.W. Dose-dependent effect of ethanol on eхtracellular dopa-
mine in mesolimbic striatum of awake rhesus monkeys:
comparison with cocaine
across individuals// Psychopharmacology. 2002. Vol. 165.
29. Buccafusco J.J. Emerging cognitive enhancing drugs//Expert Open.
emerg Drugs 2009. Vol 14. P. 577-589.
30. Buchman A.S.,Boyle P.A., Yu L. et al. Total
daily physical activity and
the risk of AD and cognitive decline in older adults // Neurology 2012 Vol. 78 P.
1323-1329.
